PL315635A1 - Method of solubilising hardly pharmaceutically active substances - Google Patents

Method of solubilising hardly pharmaceutically active substances

Info

Publication number
PL315635A1
PL315635A1 PL95315635A PL31563595A PL315635A1 PL 315635 A1 PL315635 A1 PL 315635A1 PL 95315635 A PL95315635 A PL 95315635A PL 31563595 A PL31563595 A PL 31563595A PL 315635 A1 PL315635 A1 PL 315635A1
Authority
PL
Poland
Prior art keywords
solubilising
hardly
active substances
pharmaceutically active
pharmaceutically
Prior art date
Application number
PL95315635A
Other languages
English (en)
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL315635A1 publication Critical patent/PL315635A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL95315635A 1994-01-24 1995-01-24 Method of solubilising hardly pharmaceutically active substances PL315635A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (1)

Publication Number Publication Date
PL315635A1 true PL315635A1 (en) 1996-11-25

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95315635A PL315635A1 (en) 1994-01-24 1995-01-24 Method of solubilising hardly pharmaceutically active substances

Country Status (14)

Country Link
EP (1) EP0741560A1 (pt)
JP (1) JPH09508128A (pt)
CN (1) CN1138827A (pt)
AU (1) AU706890B2 (pt)
BR (1) BR9506564A (pt)
CA (1) CA2181241C (pt)
CZ (1) CZ210496A3 (pt)
FI (1) FI962948A (pt)
MX (1) MX9602955A (pt)
NO (1) NO963052L (pt)
NZ (1) NZ279443A (pt)
PL (1) PL315635A1 (pt)
SK (1) SK96196A3 (pt)
WO (1) WO1995019759A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
CA2318128C (en) 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
NZ530889A (en) * 2001-07-31 2005-03-24 Wyeth Corp Use of sucralose as a sweetening agent combined with pH modulation of chemical formulations generates enhanced taste-masking effects
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
EP1959935A2 (en) * 2005-10-26 2008-08-27 Banner Pharmacaps Inc. Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
JP2009523119A (ja) * 2005-12-09 2009-06-18 ビーエーエスエフ ソシエタス・ヨーロピア 水に溶けにくい化合物のための可溶化剤としてのポリビニルラクタム−ポリオキシアルキレンブロックコポリマーの使用
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
RS55491B2 (sr) * 2010-01-28 2020-11-30 Eagle Pharmaceuticals Inc Formulacije bendamustina
RS65177B1 (sr) 2012-03-20 2024-03-29 Eagle Pharmaceuticals Inc Formulacije bendamustina
EP2827863B1 (en) 2012-03-20 2019-01-16 Eagle Pharmaceuticals, Inc. Liquid composition for use in a method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
BR112015018838B1 (pt) 2013-02-28 2020-12-15 Pfizer Inc. Composição oral líquida com estabilidade melhorada e seu processo para a preparação
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) * 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
NO963052L (no) 1996-09-24
CN1138827A (zh) 1996-12-25
CA2181241C (en) 2000-04-25
EP0741560A1 (en) 1996-11-13
SK96196A3 (en) 1997-03-05
CZ210496A3 (en) 1996-12-11
AU1607595A (en) 1995-08-08
WO1995019759A1 (en) 1995-07-27
JPH09508128A (ja) 1997-08-19
FI962948A0 (fi) 1996-07-23
FI962948A (fi) 1996-07-23
MX9602955A (es) 1997-06-28
AU706890B2 (en) 1999-07-01
NO963052D0 (no) 1996-07-22
CA2181241A1 (en) 1995-07-27
BR9506564A (pt) 1997-09-02
NZ279443A (en) 1998-04-27

Similar Documents

Publication Publication Date Title
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
GB9711208D0 (en) Therapeutic structure and method
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
AP2000001783A0 (en) Disinfectant and method of making
AU6564398A (en) Wagering system and method of wagering
EP0863748A4 (en) LIPOSOMAL COMPOSITIONS AND METHODS OF USE
PL336693A1 (en) Novel method of obtaining farmacologically active substances
AU5961598A (en) Pari-mutuel gaming system and method of using same
AU2502395A (en) Battery-actuated insecticide transpirator and method for transpirating insecticide
AUPN698495A0 (en) Improved therapeutic formulation and method
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
AU1970495A (en) Drug delivery device and method of construction
GB2312406B (en) One-piece end support and method of forming thereof
ZA967654B (en) Electrodes and methods of preparation thereof
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EP0851759A4 (en) COMPOUNDS AND RELATED METHODS
IL119816A0 (en) Absorbent structure and method for its manufacture
EP0761718A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
PL337513A1 (en) Novel method of obtaining pharmaceutically active compounds and their associated intermediate products
EP0761721A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0959887A4 (en) PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USING THE SAME
EP0761720A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
AU2992295A (en) Therapeutic method and compounds of use therein